Chemical Biology and Drug Design

NOVEMBER 4, 2024

Alzheimer's disease (AD) is a progressive age-related neurodegenerative brain disorder that destroys memory and other important mental functions. This review article comprehensively summarized the recent advancements in galantamine and its hybrid analogs as potential therapeutic agents for the management of AD. Furthermore, we also provided the design, synthesis, and SAR analysis of the galantamine-based compounds used in the last decades for the management of AD.

Disease 100

Disease Therapies Research 100

ASPET

NOVEMBER 4, 2024

MK-8189 is a novel phosphodiesterase 10A (PDE10A) inhibitor being evaluated in clinical studies for the treatment of schizophrenia. PDE10A is a cyclic nucleotide phosphodiesterase enzyme highly expressed in medium spiny neurons of the striatum. MK-8189 exhibits sub-nanomolar potency on the PDE10A enzyme and has excellent pharmaceutical properties. Oral administration of MK-8189 significantly increased cGMP and pGluR1 in rat striatal tissues.

Treatment 100

Treatment Clinical Trials Trials Pharmaceuticals 100

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- Alzheimer’s disease patients prescribed fistfuls of daily drugs are at greater risk of harm, a new study warns.Patients with Alzheimer’s prescribed five or more daily medications suffer from more symptoms, falls and hos.

Disease 116

Disease Drugs 116

Science Daily: Pharmacology News

NOVEMBER 4, 2024

BiomedGPT is a new a new type of artificial intelligence (AI) designed to support a wide range of medical and scientific tasks. This new study is described in the article as 'the first open-source and lightweight vision -- language foundation model, designed as a generalist capable of performing various biomedical tasks.

112

112

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- In what may be a first for the United States, a regional public health department in Idaho will no longer provide COVID-19 vaccines, following a close vote by its board.“I’m not aware of anything else like this,” said Adria.

Vaccine 105

Vaccine 105

Science Daily: Pharmacology News

NOVEMBER 4, 2024

Researchers have developed synthetic genes that function like the genes in living cells. The artificial genes can build intracellular structures through a cascading sequence that builds self-assembling structures piece by piece. The discovery offers a path toward using a suite of simple building blocks that can be programmed to make complex biomolecular materials, such as nanoscale tubes from DNA tiles.

Engineering 112

Engineering DNA Research 112

Science Daily: Pharmacology News

NOVEMBER 4, 2024

The temperature of elementary particles has been observed in the radioactive glow following the collision of two neutron stars and the birth of a black hole. This has, for the first time, made it possible to measure the microscopic, physical properties in these cosmic events. Simultaneously, it reveals how snapshot observations made in an instant represents an object stretched out across time.

108

108

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- Many people turn to mindfulness meditation to help them manage their chronic pain, a practice that’s been used for centuries.However, it’s been an open question whether meditation is simply functioning as a placebo, rather th.

105

105

Science Daily: Pharmacology News

NOVEMBER 4, 2024

The unique properties of baseball's famed 'magic' mud, which MLB equipment managers applied to every ball in the World Series, have never been scientifically quantified -- until now. Researchers now reveal what makes the magic mud so special.

Research 106

Research 106

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- Actor James Van Der Beek, perhaps best known for his role as Dawson Leery in the popular television series "Dawson's Creek," has announced that he has been diagnosed with colorectal cancer."I have colorectal cancer. I’ve b.

98

98

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Science Daily: Pharmacology News

NOVEMBER 4, 2024

Evolutionary biologists report they have analyzed a fossil of an extinct giant meat-eating bird -- which they say could be the largest known member of its kind -- providing new information about animal life in northern South America millions of years ago.

100

100

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- There's just something about sitting.New research shows that too much time on sofas and chairs harms the heart -- even among people who get the minimum recommended amount of daily exercise.“Taking a quick walk after work may.

Research 97

Research 97

Science Daily: Pharmacology News

NOVEMBER 4, 2024

Astronomers have discovered a supermassive black hole at the center of a galaxy just 1.5 billion years after the Big Bang that is consuming matter at a phenomenal rate -- over 40 times the theoretical limit. While short lived, this black hole's 'feast' could help astronomers explain how supermassive black holes grew so quickly in the early Universe.

96

96

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- Although numerous studies have shown that marijuana use during pregnancy may harm both the fetus and a mom-to-be, almost 6% of women responding to a recent survey said they used weed while pregnant.That's more than one in.

97

97

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Science Daily: Pharmacology News

NOVEMBER 4, 2024

Fifteen minutes before the massive January 2022 eruption of the Hunga Tonga-Hunga Ha'apai volcano, a seismic wave was recorded by two distant seismic stations. The researchers propose that the seismic wave was caused by a fracture in a weak area of oceanic crust beneath the volcano's caldera wall. That fracture allowed seawater and magma to pour into and mix together in the space above the volcano's subsurface magma chamber, explosively kickstarting the eruption.

Research 87

Research 87

Drugs.com

NOVEMBER 4, 2024

MONDAY, Nov. 4, 2024 -- Huntington's disease is a devastating, fatal neurological illness with little means of treatment, but a new study in mice offers a glimmer of hope. Huntington's occurs when inherited genes cause key proteins to fold and.

Disease 96

Disease Treatment 96

Drug Channels

NOVEMBER 4, 2024

Here on Drug Channels , we have long highlighted the boom in provider-administered biosimilars. In contrast to the pharmacy market, adoption of these biosimilars is growing, prices are dropping, and formulary barriers continue to fall. Novel transparency information reveals that this good news doesn’t always translate into savings. Below, we rely on a unique data set from Turquoise Health to examine how much four national commercial health plans—Aetna, Anthem, Cigna, and UnitedHealthcare—paid ho

Biosimilars 79

Biosimilars Hospitals Pharmacy Drugs 79

National Institute on Drug Abuse: Nora's Blog

NOVEMBER 4, 2024

Improving community engagement in addiction science mfleming Mon, 11/04/2024 - 19:11 Nora's Blog November 12, 2024 Image ©Getty Images/ MStudioImages Medical research can sometimes become disconnected from the interests and needs of the people it is intended to serve. This is true across diseases and disorders, and addiction research is no exception.

Science 75

Science Research Treatment Drugs 75

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Broad Institute

NOVEMBER 4, 2024

A transatlantic collaboration is uncovering the role of key genetic variants in common diseases like type 2 diabetes and obesity By Corie Lok November 4, 2024 Breadcrumb Home A transatlantic collaboration is uncovering the role of key genetic variants in common diseases like type 2 diabetes and obesity The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease brings together Danish and Broad scientists.

Disease 72

Disease Research Science International 72

DrugBank

NOVEMBER 4, 2024

The World Health Organization (WHO) estimates that if current trends persist, antibiotic resistance could cause 10 million deaths annually by 2050. The pharmaceutical industry is the primary source of antibiotic innovation; therefore, it must lead the way in combating resistance.   Urgency of Antibiotic Resistance    The escalating threat of antibiotic resistance is an incoming global crisis projected to affect international health and the economy.

Pharmaceutical Companies 71

Pharmaceutical Companies Government Pharmaceuticals DNA 71

NIOSH Science Blog: Drugs

NOVEMBER 4, 2024

Respirable crystalline silica (RCS), most commonly in the form of quartz, is a known health hazard in many industries. Exposure to RCS can lead to debilitating and incurable diseases. To minimize the risk of health effects associated with exposure, the Mine Safety and Health Administration (MSHA) released a final rule for lowering miners’ exposure to RCS in April 2024.

Disease 70

Disease 70

Drug Patent Watch

NOVEMBER 4, 2024

The development and use of generic drugs have significant implications for healthcare systems and economies worldwide.

Drug Development 86

Drug Development Drugs Pharmaceuticals Production 86

The ChEMBL-og

NOVEMBER 4, 2024

Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL. This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second.

Packaging 67

Packaging Engineering 67

BioPharma Drive: Drug Pricing

NOVEMBER 4, 2024

Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the company still slipped.

Therapies 70

Therapies Drugs 70

FDA Law Blog: Biosimilars

NOVEMBER 4, 2024

By Sara W. Koblitz & Charles D. Snow & Karla L. Palmer & John W.M. Claud — As we reported back in January, Phibro Animal Health Corporation challenged FDA’s decision to remove a drug called carbadox—used as an antimicrobial drug to treat gastrointestinal disease in food-producing pigs—from the market. More specifically, FDA rescinded approval of a “regulatory method” that Phibro used to establish that carbadox is safe and effective.

FDA 62

FDA Drugs Marketing Production 62

BioPharma Drive: Drug Pricing

NOVEMBER 4, 2024

Bio-Rad’s extensive ddPCR assay offerings help researchers leverage the full power of digital PCR.

Research 83

Research 83

Science Daily: Pharmacology News

NOVEMBER 4, 2024

Extraordinarily well preserved fossils of feathered dinosaurs and other creatures got that way after being frozen in time by by volcanic eruptions, researchers have long suggested. Not so fast, says a new study.

Research 60

Research 60

BioPharma Drive: Drug Pricing

NOVEMBER 4, 2024

Per terms, Novo could pay up to $285 million in upfront and milestone fees to Ascendis, which specializes in a kind of drug-enhancing technology.

Drugs 67

Drugs 67

Covalent Modifiers

NOVEMBER 4, 2024

Jinhyuk Kim, Hadong Kim, Jongwan Kim, Seon Yeon Cho, Sungho Moon, Youngki Yoo, Hanseong Kim, Jin Kwan Kim, Hyejin Jeon, Wan Namkung, Gyoonhee Han, and Kyoung Tai No Journal of Medicinal Chemistry 2024 DOI: 10.1021/acs.jmedchem.4c01393 I n the Hippo signaling pathway, the palmitoylated transcriptional enhanced associated domain (TEAD) protein interacts with the coactivator Yes-associated protein/PDZ-binding motif, leading to transcriptional upregulation of oncogenes such as Ctgf and Cyr61.

Drugs 58

Drugs 58

BioPharma Drive: Drug Pricing

NOVEMBER 4, 2024

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett syndrome may turn out positive.

Therapies 60

Therapies 60

Alta Sciences

NOVEMBER 4, 2024

Nonclinical Experts Discuss the Promise of Gene Therapy blussier Mon, 11/04/2024 - 21:08 HTML Driving Progress in Gene Therapy Altasciences is a leader in nonclinical research, including gene therapy. In this video, our experts discuss the latest advancements and challenges in the field, while showcasing how our cutting-edge facilities are specifically tailored to support your innovative gene therapy projects.

Therapies 52

Therapies Production Research 52

Broad Institute

NOVEMBER 4, 2024

Broad-MIT Seminars in Chemical Biology: Jim Wells By Rose Circeo November 4, 2024 Breadcrumb Home Broad-MIT Seminars in Chemical Biology: Jim Wells Broad-MIT Seminars in Chemical Biology November 4, 2024 MIT Jim Wells University of California, San Francisco Pirating Proteins to Attack the Surfaceome

52

52

Alta Sciences

NOVEMBER 4, 2024

[NEW VIDEO] Nonclinical Experts Discuss the Promise of Gene Therapy blussier Mon, 11/04/2024 - 21:08 HTML Driving Progress in Gene Therapy Altasciences is a leader in nonclinical research, including gene therapy. In this video, our experts discuss the latest advancements and challenges in the field, while showcasing how our cutting-edge facilities are specifically tailored to support your innovative gene therapy projects.

Therapies 52

Therapies Production Research 52